Join
Live feed
·
INSIDERFilingvia Quantisnow
Travere Therapeutics Inc. logo

CHIEF MEDICAL OFFICER Inrig Jula was granted 28,130 shares and sold $223,427 worth of shares (6,956 units at $32.12), increasing direct ownership by 25% to 107,485 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track TVTX (Travere Therapeutics Inc.) and more on Quantisnow.